ClinVar Genomic variation as it relates to human health
NM_000546.6(TP53):c.412_417dup (p.Lys139_Thr140insAlaLys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000546.6(TP53):c.412_417dup (p.Lys139_Thr140insAlaLys)
Variation ID: 3328170 Accession: VCV003328170.1
- Type and length
-
Duplication, 6 bp
- Location
-
Cytogenetic: 17p13.1 17: 7675194-7675195 (GRCh38) [ NCBI UCSC ] 17: 7578512-7578513 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Aug 11, 2024 Aug 11, 2024 May 6, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000546.6:c.412_417dup MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000537.3:p.Lys139_Thr140insAlaLys inframe insertion NM_001126112.3:c.412_417dup NP_001119584.1:p.Lys139_Thr140insAlaLys inframe insertion NM_001126113.3:c.412_417dup NP_001119585.1:p.Lys139_Thr140insAlaLys inframe insertion NM_001126114.3:c.412_417dup NP_001119586.1:p.Lys139_Thr140insAlaLys inframe insertion NM_001126115.2:c.16_21dup NP_001119587.1:p.Lys7_Thr8insAlaLys inframe insertion NM_001126116.2:c.16_21dup NP_001119588.1:p.Lys7_Thr8insAlaLys inframe insertion NM_001126117.2:c.16_21dup NP_001119589.1:p.Lys7_Thr8insAlaLys inframe insertion NM_001126118.2:c.295_300dup NP_001119590.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001276695.3:c.295_300dup NP_001263624.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001276696.3:c.295_300dup NP_001263625.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001276697.3:c.-66_-61dup 5 prime UTR NM_001276698.3:c.-66_-61dup 5 prime UTR NM_001276699.3:c.-66_-61dup 5 prime UTR NM_001276760.3:c.295_300dup NP_001263689.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001276761.3:c.295_300dup NP_001263690.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001407262.1:c.412_417dup NP_001394191.1:p.Lys139_Thr140insAlaLys inframe insertion NM_001407263.1:c.295_300dup NP_001394192.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001407264.1:c.412_417dup NP_001394193.1:p.Lys139_Thr140insAlaLys inframe insertion NM_001407265.1:c.295_300dup NP_001394194.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001407266.1:c.412_417dup NP_001394195.1:p.Lys139_Thr140insAlaLys inframe insertion NM_001407267.1:c.295_300dup NP_001394196.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001407268.1:c.412_417dup NP_001394197.1:p.Lys139_Thr140insAlaLys inframe insertion NM_001407269.1:c.295_300dup NP_001394198.1:p.Lys100_Thr101insAlaLys inframe insertion NM_001407270.1:c.412_417dup NP_001394199.1:p.Lys139_Thr140insAlaLys inframe insertion NM_001407271.1:c.295_300dup NP_001394200.1:p.Lys100_Thr101insAlaLys inframe insertion NR_176326.1:n.554_559dup non-coding transcript variant NC_000017.11:g.7675196_7675201dup NC_000017.10:g.7578514_7578519dup NG_017013.2:g.17351_17356dup LRG_321:g.17351_17356dup LRG_321t1:c.411_416dup LRG_321p1:p.Lys139_Thr140insAlaLys LRG_321t2:c.411_416dup LRG_321:p.Lys139_Thr140insAlaLys LRG_321t3:c.411_416dup LRG_321p3:p.Lys139_Thr140insAlaLys LRG_321t4:c.411_416dup LRG_321p4:p.Lys139_Thr140insAlaLys LRG_321t5:c.15_20dup LRG_321p5:p.Lys7_Thr8insAlaLys LRG_321t6:c.15_20dup LRG_321p6:p.Lys7_Thr8insAlaLys LRG_321t7:c.15_20dup LRG_321p7:p.Lys7_Thr8insAlaLys LRG_321t8:c.294_299dup LRG_321p8:p.Lys100_Thr101insAlaLys - Protein change
- -
- Other names
- -
- Canonical SPDI
- NC_000017.11:7675194:CTTGGCC:CTTGGCCTTGGCC
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TP53 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
3373 | 3472 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
May 6, 2024 | RCV004677204.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(May 06, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV005177944.1
First in ClinVar: Aug 11, 2024 Last updated: Aug 11, 2024 |
Comment:
The c.412_417dupGCCAAG variant (also known as p.A138_K139dup), located in coding exon 4 of the TP53 gene, results from an in-frame duplication of GCCAAG at nucleotide … (more)
The c.412_417dupGCCAAG variant (also known as p.A138_K139dup), located in coding exon 4 of the TP53 gene, results from an in-frame duplication of GCCAAG at nucleotide positions 412 to 417. This results in the duplication of 2 extra residues (AK) between codons 138 and 139. This amino acid region is highly conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated Aug 11, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.